COMMUNIQUÉS West-GlobeNewswire

-
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
15/04/2025 - 14:15 -
Best Probiotic for Bloating and Gas 2025 - Top Probiotic Supplements for Gut Health from YourBiology
15/04/2025 - 14:18 -
Biomerica Reports Third Quarter Fiscal 2025 Financial Results
15/04/2025 - 14:19 -
Entera Bio’s EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO
15/04/2025 - 14:30 -
BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial
15/04/2025 - 14:30 -
Vivos Inc. Reports Continued Progress in India Human Clinical Trial for RadioGel® Precision Radionuclide Therapy™
15/04/2025 - 14:30 -
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
15/04/2025 - 14:30 -
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
15/04/2025 - 14:30 -
MAPS Announces MDMA-Assisted Therapy Education Event For Ukrainian Mental Health Practitioners
15/04/2025 - 14:30 -
KFSHRC Treats Artery Blockage with Innovative Non-Surgical Technique
15/04/2025 - 14:30 -
Sienna Announces April Dividend
15/04/2025 - 14:43 -
Parexel appoints Charlotte Moser, MD, PhD, MBA as Chief Medical Officer
15/04/2025 - 14:57 -
Confluent Health Honors Physical Therapy Leaders for Service to Patients and Communities
15/04/2025 - 14:59 -
LiveWorld Releases First-Ever AI Brand Reputation Index for Leading Pharmaceutical Brands
15/04/2025 - 15:00 -
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
15/04/2025 - 15:00 -
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
15/04/2025 - 15:00 -
Ezra Appoints Dr. Danna Chung as Chief Medical Officer
15/04/2025 - 15:01 -
HealthEquity’s Expedited Claims Technology Wins Artificial Intelligence Excellence Awards
15/04/2025 - 15:20 -
Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets
15/04/2025 - 15:26
Pages